1. Home
  2. NRSN vs PED Comparison

NRSN vs PED Comparison

Compare NRSN & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • PED
  • Stock Information
  • Founded
  • NRSN 2017
  • PED N/A
  • Country
  • NRSN Israel
  • PED United States
  • Employees
  • NRSN N/A
  • PED N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • PED Oil & Gas Production
  • Sector
  • NRSN Health Care
  • PED Energy
  • Exchange
  • NRSN Nasdaq
  • PED Nasdaq
  • Market Cap
  • NRSN 50.1M
  • PED 48.8M
  • IPO Year
  • NRSN 2021
  • PED N/A
  • Fundamental
  • Price
  • NRSN $1.77
  • PED $0.66
  • Analyst Decision
  • NRSN Buy
  • PED Strong Buy
  • Analyst Count
  • NRSN 2
  • PED 1
  • Target Price
  • NRSN $14.00
  • PED $1.50
  • AVG Volume (30 Days)
  • NRSN 225.6K
  • PED 126.0K
  • Earning Date
  • NRSN 08-05-2025
  • PED 08-13-2025
  • Dividend Yield
  • NRSN N/A
  • PED N/A
  • EPS Growth
  • NRSN N/A
  • PED 2248.88
  • EPS
  • NRSN N/A
  • PED 0.19
  • Revenue
  • NRSN N/A
  • PED $40,173,000.00
  • Revenue This Year
  • NRSN N/A
  • PED N/A
  • Revenue Next Year
  • NRSN N/A
  • PED $5.99
  • P/E Ratio
  • NRSN N/A
  • PED $3.50
  • Revenue Growth
  • NRSN N/A
  • PED 30.70
  • 52 Week Low
  • NRSN $0.60
  • PED $0.47
  • 52 Week High
  • NRSN $2.60
  • PED $1.07
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 39.25
  • PED 52.57
  • Support Level
  • NRSN $1.69
  • PED $0.62
  • Resistance Level
  • NRSN $2.09
  • PED $0.69
  • Average True Range (ATR)
  • NRSN 0.15
  • PED 0.03
  • MACD
  • NRSN -0.04
  • PED 0.00
  • Stochastic Oscillator
  • NRSN 17.78
  • PED 50.00

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About PED Pedevco Corp.

PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.

Share on Social Networks: